ZA991841B - Chemical Compounds. - Google Patents
Chemical Compounds.Info
- Publication number
- ZA991841B ZA991841B ZA9901841A ZA991841A ZA991841B ZA 991841 B ZA991841 B ZA 991841B ZA 9901841 A ZA9901841 A ZA 9901841A ZA 991841 A ZA991841 A ZA 991841A ZA 991841 B ZA991841 B ZA 991841B
- Authority
- ZA
- South Africa
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9804861.4A GB9804861D0 (en) | 1998-03-06 | 1998-03-06 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991841B true ZA991841B (en) | 1999-09-08 |
Family
ID=10828156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901841A ZA991841B (en) | 1998-03-06 | 1999-03-08 | Chemical Compounds. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7235552B1 (cs) |
| EP (1) | EP1060188A1 (cs) |
| JP (1) | JP2002505336A (cs) |
| KR (1) | KR100690037B1 (cs) |
| CN (1) | CN1177860C (cs) |
| AU (1) | AU752992B2 (cs) |
| CA (1) | CA2319763C (cs) |
| CZ (1) | CZ298478B6 (cs) |
| GB (1) | GB9804861D0 (cs) |
| HU (1) | HUP0100854A3 (cs) |
| IL (1) | IL138137A (cs) |
| NO (1) | NO317378B1 (cs) |
| NZ (1) | NZ506139A (cs) |
| WO (1) | WO1999045024A1 (cs) |
| ZA (1) | ZA991841B (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2247102T3 (es) * | 2000-05-11 | 2006-03-01 | Research Institute For Medicine And Chemistry Inc. | Derivados de cola-1,3,5(10)-trieno y pregna-1,3,5(10)-trieno 2-sustituidos y su actividad biologica. |
| EP1514874A1 (en) * | 2003-07-28 | 2005-03-16 | Schering Aktiengesellschaft | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| WO2009059239A2 (en) * | 2007-11-02 | 2009-05-07 | Mayo Foundation For Medical Education And Research | REDUCING Aβ42 LEVELS AND Aβ AGGREGATION |
| KR20200022525A (ko) | 2008-12-04 | 2020-03-03 | 충시 위 | 고투과력을 가진 조성물 및 이의 적용 |
| US8987235B2 (en) | 2011-05-17 | 2015-03-24 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses |
| WO2013013221A1 (en) | 2011-07-20 | 2013-01-24 | Brigham Young University | Hydrophobic ceragenin compounds and devices incorporating same |
| US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| JP6518230B2 (ja) | 2013-03-15 | 2019-05-22 | ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ | 炎症、自己免疫疾患、および疼痛を治療する方法 |
| US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
| US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
| US9434759B1 (en) * | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
| US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
| EP3275888B1 (en) * | 2016-07-28 | 2019-09-25 | Council of Scientific & Industrial Research | Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof |
| US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
| US12186328B2 (en) | 2019-05-23 | 2025-01-07 | Brigham Young University | Use of CSA compounds to stimulate stem cells and hair growth |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1512326A (fr) | 1964-03-27 | 1968-02-09 | Roussel Uclaf | Nouveaux stéroïdes azotés et procédé de préparation |
| US4217288A (en) * | 1977-03-24 | 1980-08-12 | Wisconsin Alumni Research Foundation | Anti-vitamin D compounds |
| US4172076A (en) * | 1977-04-04 | 1979-10-23 | Diamond Shamrock Corporation | Process for preparing steroidal acids and their intermediate derivatives |
| FR2426044A2 (fr) * | 1978-05-19 | 1979-12-14 | Wisconsin Research Foundation | Derives de la vitamine d3 ayant une activite anti-vitamine d |
| GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
| PL171580B1 (pl) * | 1991-11-07 | 1997-05-30 | Res Inst Medicine Chem | Sposób wytwarzania nowych analogów witaminy D3 PL PL PL |
| JP3493037B2 (ja) * | 1991-12-18 | 2004-02-03 | 中外製薬株式会社 | ２２−オキサコレカルシフェロール誘導体とその製造方法 |
| IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
| GB9309422D0 (en) * | 1993-05-07 | 1993-06-23 | Res Inst Medicine Chem | Chemical compounds |
| AU3068497A (en) * | 1996-05-06 | 1997-11-26 | Bionumerik Pharmaceuticals, Inc. | Process for preparing 27-hydroxy cholesterol and related derivatives |
| PL334840A1 (en) * | 1997-01-24 | 2000-03-27 | Univ California | Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation |
-
1998
- 1998-03-06 GB GBGB9804861.4A patent/GB9804861D0/en not_active Ceased
-
1999
- 1999-03-08 KR KR1020007009596A patent/KR100690037B1/ko not_active Expired - Fee Related
- 1999-03-08 WO PCT/GB1999/000681 patent/WO1999045024A1/en active IP Right Grant
- 1999-03-08 JP JP2000534566A patent/JP2002505336A/ja active Pending
- 1999-03-08 NZ NZ506139A patent/NZ506139A/xx unknown
- 1999-03-08 HU HU0100854A patent/HUP0100854A3/hu unknown
- 1999-03-08 IL IL13813799A patent/IL138137A/xx not_active IP Right Cessation
- 1999-03-08 EP EP99937931A patent/EP1060188A1/en not_active Withdrawn
- 1999-03-08 CA CA002319763A patent/CA2319763C/en not_active Expired - Fee Related
- 1999-03-08 CZ CZ20003253A patent/CZ298478B6/cs not_active IP Right Cessation
- 1999-03-08 AU AU32675/99A patent/AU752992B2/en not_active Ceased
- 1999-03-08 ZA ZA9901841A patent/ZA991841B/xx unknown
- 1999-03-08 CN CNB998036935A patent/CN1177860C/zh not_active Expired - Fee Related
-
2000
- 2000-08-01 US US09/630,546 patent/US7235552B1/en not_active Expired - Fee Related
- 2000-09-04 NO NO20004399A patent/NO317378B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1177860C (zh) | 2004-12-01 |
| IL138137A (en) | 2005-11-20 |
| HUP0100854A3 (en) | 2002-09-30 |
| NO317378B1 (no) | 2004-10-18 |
| NZ506139A (en) | 2003-06-30 |
| CA2319763C (en) | 2008-01-15 |
| US7235552B1 (en) | 2007-06-26 |
| KR20010041446A (ko) | 2001-05-25 |
| CN1292797A (zh) | 2001-04-25 |
| EP1060188A1 (en) | 2000-12-20 |
| WO1999045024A1 (en) | 1999-09-10 |
| AU752992B2 (en) | 2002-10-03 |
| GB9804861D0 (en) | 1998-04-29 |
| HUP0100854A2 (hu) | 2001-09-28 |
| NO20004399L (no) | 2000-11-03 |
| IL138137A0 (en) | 2001-10-31 |
| CZ298478B6 (cs) | 2007-10-17 |
| KR100690037B1 (ko) | 2007-03-08 |
| AU3267599A (en) | 1999-09-20 |
| JP2002505336A (ja) | 2002-02-19 |
| CZ20003253A3 (cs) | 2001-03-14 |
| CA2319763A1 (en) | 1999-09-10 |
| NO20004399D0 (no) | 2000-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9810125B (en) | Chemical compounds. | |
| GB9800428D0 (en) | Chemical compounds | |
| GB9812709D0 (en) | Chemical compounds | |
| GB9811159D0 (en) | Chemical compounds | |
| GB9812088D0 (en) | Chemical compounds | |
| GB9804343D0 (en) | Chemical compounds | |
| ZA991841B (en) | Chemical Compounds. | |
| ZA991032B (en) | Chemical compounds. | |
| GB9928746D0 (en) | Chemical compounds | |
| ZA981791B (en) | Chemical compound. | |
| ZA99688B (en) | Chemical compounds. | |
| GB9802028D0 (en) | Chemical compounds | |
| GB9809161D0 (en) | Chemical compounds | |
| ZA981876B (en) | Chemical compounds. | |
| ZA99373B (en) | Chemical compounds. | |
| GB9812021D0 (en) | Chemical compounds | |
| GB9812726D0 (en) | Chemical compounds | |
| GB9813528D0 (en) | Chemical compounds | |
| GB9807579D0 (en) | Chemical compounds | |
| GB9807578D0 (en) | Chemical compounds | |
| GB9807577D0 (en) | Chemical compounds | |
| GB9807576D0 (en) | Chemical compounds | |
| GB9807394D0 (en) | Chemical compounds | |
| GB9806309D0 (en) | Chemical compounds | |
| GB9805498D0 (en) | Chemical compounds |